Evolutionary Genomics Pink Sheet Forecast - Simple Regression

FNAM Stock  USD 0.0002  0.00  0.00%   
The Simple Regression forecasted value of Evolutionary Genomics on the next trading day is expected to be 0.0002 with a mean absolute deviation of 0 and the sum of the absolute errors of 0. Evolutionary Pink Sheet Forecast is based on your current time horizon.
  
Simple Regression model is a single variable regression model that attempts to put a straight line through Evolutionary Genomics price points. This line is defined by its gradient or slope, and the point at which it intercepts the x-axis. Mathematically, assuming the independent variable is X and the dependent variable is Y, then this line can be represented as: Y = intercept + slope * X.

Evolutionary Genomics Simple Regression Price Forecast For the 27th of December

Given 90 days horizon, the Simple Regression forecasted value of Evolutionary Genomics on the next trading day is expected to be 0.0002 with a mean absolute deviation of 0, mean absolute percentage error of 0, and the sum of the absolute errors of 0.
Please note that although there have been many attempts to predict Evolutionary Pink Sheet prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Evolutionary Genomics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).

Evolutionary Genomics Pink Sheet Forecast Pattern

Backtest Evolutionary GenomicsEvolutionary Genomics Price PredictionBuy or Sell Advice 

Evolutionary Genomics Forecasted Value

In the context of forecasting Evolutionary Genomics' Pink Sheet value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Evolutionary Genomics' downside and upside margins for the forecasting period are 0.0002 and 0.0002, respectively. We have considered Evolutionary Genomics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Market Value
0.0002
0.0002
Downside
0.0002
Expected Value
0.0002
Upside

Model Predictive Factors

The below table displays some essential indicators generated by the model showing the Simple Regression forecasting method's relative quality and the estimations of the prediction error of Evolutionary Genomics pink sheet data series using in forecasting. Note that when a statistical model is used to represent Evolutionary Genomics pink sheet, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.
AICAkaike Information Criteria31.7852
BiasArithmetic mean of the errors None
MADMean absolute deviation0.0
MAPEMean absolute percentage error0.0
SAESum of the absolute errors0.0
In general, regression methods applied to historical equity returns or prices series is an area of active research. In recent decades, new methods have been developed for robust regression of price series such as Evolutionary Genomics historical returns. These new methods are regression involving correlated responses such as growth curves and different regression methods accommodating various types of missing data.

Predictive Modules for Evolutionary Genomics

There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Evolutionary Genomics. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.
Hype
Prediction
LowEstimatedHigh
0.000.00020.00
Details
Intrinsic
Valuation
LowRealHigh
0.000.00020.00
Details
Bollinger
Band Projection (param)
LowMiddleHigh
0.00020.00020.0002
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Evolutionary Genomics. Your research has to be compared to or analyzed against Evolutionary Genomics' peers to derive any actionable benefits. When done correctly, Evolutionary Genomics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Evolutionary Genomics.

Other Forecasting Options for Evolutionary Genomics

For every potential investor in Evolutionary, whether a beginner or expert, Evolutionary Genomics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Evolutionary Pink Sheet price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Evolutionary. Basic forecasting techniques help filter out the noise by identifying Evolutionary Genomics' price trends.

Evolutionary Genomics Related Equities

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Evolutionary Genomics pink sheet to make a market-neutral strategy. Peer analysis of Evolutionary Genomics could also be used in its relative valuation, which is a method of valuing Evolutionary Genomics by comparing valuation metrics with similar companies.
 Risk & Return  Correlation

Evolutionary Genomics Technical and Predictive Analytics

The pink sheet market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Evolutionary Genomics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Evolutionary Genomics' current price.

Evolutionary Genomics Market Strength Events

Market strength indicators help investors to evaluate how Evolutionary Genomics pink sheet reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Evolutionary Genomics shares will generate the highest return on investment. By undertsting and applying Evolutionary Genomics pink sheet market strength indicators, traders can identify Evolutionary Genomics entry and exit signals to maximize returns.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet

Other Information on Investing in Evolutionary Pink Sheet

Evolutionary Genomics financial ratios help investors to determine whether Evolutionary Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Evolutionary with respect to the benefits of owning Evolutionary Genomics security.